H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 135,470. Connecticut Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Stamford clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Stamford storefront.
Growth Factor Therapy for Tissue Repair in Stamford, CT for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
Stamford is a city under 250k (135,470 Census). CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Stamford we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 8.6% of adults in Stamford have diagnosed diabetes — 3.4 points below the U.S. 12% figure.
We are not going to invent a Stamford warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 25.5%; arthritis is 19.3%. That is place-level BRFSS modeling, not a clinic census and not a Stamford trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Connecticut.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
Ask for the IFU, the lot-traceability packet, and the National Government Services (NGS) article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Stamford fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Stamford, CT.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Stamford is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Stamford — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Connecticut Part B wound biologics follow this contractor (siblings: MA, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Stamford. Useful for joint-program math; still needs a diagnosis and privileging.
No Stamford storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.